Blue Steens newsletter icon

Check out my latest monthly review! It showcases Blue Steens’ latest posts, some news from biopharma & medtech as well as interesting events I have attended or noticed.

At a glance

In terms of COVID-19, we’ve seen interesting technologies being added to the spectrum of testing capabilities; hydroxychloroquine as a potential treatment seems to be falling from favour whilst remdesivir is going strong; DNA & mRNA vaccines have been making it into clinical trials and cows can now produce human antibodies. In addition, I noticed some other exciting stories about biotech & medtech developments. Replays to a few virtual events can also be found at the end.

Click to read >>>